Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1/2 1

Status

Unknown 3Not yet recruiting 1Completed 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gynecologic 5Gastrointestinal 1

Conditions

Uterine Cervical Neoplasms 5Endometrial Neoplasms 4Ovarian Neoplasms 2Locally Advanced Cervical Carcinoma 2Turcot syndrome 1Stomach Neoplasms 1Recurrent/ Advanced Stage Endometrial Cancer Patients 1Recurrence 1Esophageal Neoplasms 1Colorectal Neoplasms 1Carcinoma, Endometrioid 1Advanced Cervical Cancer 1

Interventions

Cisplatin 182Radiotherapy 81Paclitaxel 80Brachytherapy 74Carboplatin 72pembrolizumab 63Bevacizumab 40Surveys and Questionnaires 29Colposcopy 29Radiation 28Gemcitabine 28Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 27Topotecan 26Magnetic Resonance Spectroscopy 24Blood Specimen Collection 23human papillomavirus vaccine, L1 type 16, 18 22Nivolumab 22Drug Therapy 22Papillomavirus Vaccines 20atezolizumab 19Platinum 19Radiotherapy, Intensity-Modulated 18Biopsy 18Docetaxel 17Taxes 16Cyclophosphamide 16Early Intervention, Educational 151,2-diaminocyclohexaneplatinum II citrate 15Methods 14fludarabine 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Uterine Cervical Neoplasms × sintilimab × Gynecologic × Clear all
NCT05383482 2025-11-17

Afuresertib +Sintilimab+Chemotherapy in Patients With Selected Solid Tumors That Resistance to Prior Anti-PD-1/PD-L1

Laekna Limited

Phase 1/2 Completed
22 enrolled
GastrointestinalGynecologic

Uterine Cervical Neoplasms, Esophageal Neoplasms, Endometrial Neoplasms

NCT07088731 2025-09-22

Clinical Study to Evaluate the Efficacy and Safety of Nab-Paclitaxel Combined With Cisplatin and Sintilimab in Neoadjuvant Treatment of Locally Advanced Cervical Cancer

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Not yet recruiting
180 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT05105672 2021-12-28

A Study of Sintilimab Combined With Concurrent Chemoradiation Therapy in Locally Advanced Cervical Cancer

The Affiliated Hospital of Xuzhou Medical University

Phase 2 Unknown
20 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT04918628 2021-06-09

CRTCP

Taizhou Hospital

Phase 2 Unknown
50 enrolled
Gynecologic

Uterine Cervical Neoplasms

NCT04096911 2019-09-20

Combination of PD-1 Monoclonal Antibody and HPV Vaccine in Patients With Cervical Cancer

Northern Jiangsu People's Hospital

Phase 2 Unknown
20 enrolled
Gynecologic

Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡